Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cathay World Investment Limited is an investment holding company based in Hong Kong and is a subsidiary of Cathay Financial Holding Co., Ltd., one of Taiwan's largest financial services groups. While the entity itself is not a biotechnology or pharmaceutical developer, it serves as a strategic investment vehicle for its parent company, which has significant exposure to the life sciences sector through various venture capital and private equity holdings. Notably, Cathay World Investment has been identified as a shareholder in major industrial biotechnology firms, such as Cathay Biotech Inc. (Shanghai Cathay Industrial Biotech). The company's primary function is to manage capital and equity stakes rather than conducting research and development or clinical trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CatheyWorldInvestment.